Update Jan. 20, 2021: The North America myopia trial is nearing the end of its second year and it is closed to enrollment. Based on the one-year data, the eyeglasses have regulatory approval to be sold as medical devices in Europe and Canada. They are currently being sold in Canada under the brand name "Kikko." Researchers anticipate regulatory approval in the United States in about a year that will be based on the two-year results. People can go to the Kikko website https://kikkovision.com/ and sign up to receive updates about U.S. availability. Once they are approved in the U.S., people will be able to buy the glasses from their optometrist or ophthalmologist.